Ambient Air Pollution and Congenital Heart Disease: Updated Evidence and Future Challenges

Francesca Gorini1, Alessandro Tonacci1

  • 1Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

PubMed

Insights

Maternal exposure to air pollution, particularly particulate matter (PM), is linked to congenital heart disease (CHD) risk. Further research is needed to confirm links with other pollutants and inform interventions.

Area of Science:

  • Environmental Health
  • Pediatric Cardiology
  • Reproductive Toxicology

Background:

  • Congenital heart disease (CHD) is a leading cause of infant mortality globally.
  • Maternal exposure to environmental factors, including air pollution, is implicated in CHD development.
  • Ambient air pollutants encompass particulate matter (PM), ozone, nitrogen dioxide, sulfur dioxide, and carbon monoxide.

Purpose of the Study:

  • To review current evidence on the association between maternal exposure to outdoor air pollutants and CHD.
  • To explore potential biological mechanisms underlying this association.
  • To identify research gaps and future directions.

Main Methods:

  • Literature review of human and experimental studies.
  • Analysis of updated evidence on various air pollutants and CHD risk.
  • Exploration of biological pathways.

Main Results:

  • Moderate evidence links particulate matter (PM) exposure during pregnancy to increased overall CHD risk.
  • Ozone exposure in the periconceptional period shows a potential association with increased CHD risk.
  • Evidence for other pollutants (nitrogen dioxide, sulfur dioxide, carbon monoxide) is inconsistent.

Conclusions:

  • Particulate matter and potentially ozone are associated with congenital heart disease risk.
  • More research, including large cohort studies and animal models, is needed for other pollutants.
  • Improved pollutant monitoring and AI analysis are crucial for understanding environmental impacts on CHD.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...